The following is a brief introduction to some international medical stocks:

Eli Lilly and Company (LLY)

• Company Profile : It is a global pharmaceutical company engaged in the discovery, development, and marketing of human pharmaceuticals. Its products cover various therapeutic areas such as diabetes, oncology, immunology, neuroscience, and more. For example, it offers a range of insulin products for diabetes treatment, including Basaglar, Humalog, and Humulin series, as well as drugs like Jardiance, Mounjaro, and Trulicity for type 2 diabetes, and Zepbound for obesity.

• Stock Performance : As of February 23, 2025, NYSE: LLY traded at $874.12, with a 52-week low of $711.40 and a 52-week high of $972.53. The company has a market capitalization of $828.82 billion, a PE ratio of 74.65, and a beta of 0.42.

Walmart (WMT)

• Company Profile : Walmart is a multinational retail corporation that operates retail, wholesale, and other units, as well as eCommerce worldwide. Its Walmart U.S. segment includes supercenters, supermarkets, and discount stores, while Walmart International covers operations in various countries. Although not primarily a medical company, it has a significant presence in the healthcare space through its pharmacies and healthcare services offered in its stores.

• Stock Performance : On February 23, 2025, WMT stock traded at $94.70, with a 52-week low of $57.77 and a 52-week high of $105.30. The company has a market cap of $760.77 billion and a P/E ratio of 39.30.

Meihua International Medical Technologies (MHUA)

• Company Profile : Founded in 1991 and based in Yangzhou, China, it is engaged in the manufacture, sale, and marketing of medical consumables. Its products include class I, II, and III disposable medical devices, such as non-bottled products like brushes and ID bracelets, and polyethylene bottled products like eye drop and tablet bottles. It also distributes disposable medical devices from other manufacturers and exports its products to Europe, North America, South America, Asia, Africa, and Oceania.

• Stock Performance : As of January 19, 2025, MHUA's market capitalization was $8.92 million. The stock was trading at $0.3557, with a volume of 240,350 shares.

UnitedHealth Group (UNH)

• Company Profile : It is a diversified healthcare company in the United States, operating through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. It provides a wide range of healthcare services, including health benefit plans, healthcare coverage, health and well-being services, Medicaid plans, children's health insurance, and more.

• Stock Performance : On February 24, 2025, UNH traded at $462.07, with a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market capitalization of $425.24 billion, a P/E ratio of 29.83, and a beta of 0.61.

Johnson & Johnson (JNJ)

• Company Profile : A holding company that engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments, focusing on areas such as immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

• Stock Performance : On February 24, 2025, JNJ traded at $163.39, with a 52-week low of $140.68 and a 52-week high of $168.85. The company has a market cap of $393.37 billion and a P/E ratio of 24.57.

Tempus AI (TEM)

• Company Profile : A technology company that advances precision medicine through the practical application of artificial intelligence in healthcare. It provides AI-enabled precision medicine solutions to physicians for personalized patient care and facilitates the discovery, development, and delivery of optimal therapeutics.

• Stock Performance : On February 24, 2025, TEM traded at $71.70, with a 50-day moving average price of $50.29 and a 200-day moving average price of $51.82.

Merck & Co., Inc. (MRK)

• Company Profile : A healthcare company that provides health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the Pharmaceutical, Animal Health, and Other segments.

• Stock Performance : On February 24, 2025, MRK traded at $90.78, with a 52-week low of $81.04 and a 52-week high of $134.63. The company has a market cap of $229.63 billion and a P/E ratio of 13.50.